Home
MiRXES

MiRXES Market Share Analysis for April 2026

The ID3EAL™ PanoramiR Knowledge Panel is an effective approach for profiling miRNAs important in biological processes, disease mechanisms, or biomarker discovery for clinical applications such as disease diagnosis and prognosis, disease stratification or treatment selection.

Health > Health - Other

Domainmirxes.com

Year Founded2014

Employees51 - 200

Annual Revenue$15M - $25M

MiRXES

MiRXES (including company regionals)

mirxes.com

See more website traffic and engagement information

MiRXES Revenue up to April 2026 is 15M - 25M

revenue generated by MiRXES top domains

MiRXES top domains revenue over 3 years

Revenue for MiRXES top domains

mirxes.com15M - 25M

See more with Sales Intelligence

Total visits to MiRXES's top domains

Understand MiRXES market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

mirxes.com9K

See more with Sales Intelligence

Avg. visit duration in MiRXES's top domains

Analyze MiRXES engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

mirxes.com00:00:17

See more with Sales Intelligence

Avg. pageviews on MiRXES's top domains

See how MiRXES keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

mirxes.com2.97

See more with Sales Intelligence

MiRXES top competitors by domain

Top similar sites in April 2026, ranked by their affinity

ncis.com.sgCompany NameNCIS StoriesEmployees1001 - 5000HQSingapore, SingaporeAnnual revenue$5M - $10MTotal visits15.6KHealth > Health - Other

Top technologies used by MiRXES

These are the website technologies, by industry, used by MiRXES top domains

Widget (8)

Twemoji

Advertising (5)

DoubleClick

Content Management System (3)

WordPress

Email Services (3)

Microsoft Exchange Online

More Technologies

13

See all

News & Signals from MiRXES

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMiRXES Pte. Ltd. launches range of at-home screening test kits: FITRapid.In a simultaneous move to democratize diagnostics, Mirxes announced the Thailand launch of its new range of at-home screening test kits: FITRapid and HELICORapid, following Thailand FDA approvals in October 2025 and December 2025 respectively.

NewsMiRXES Pte. Ltd. received financing of $139M in initial public offering on May 1st '25.Mirxes, a Singapore-based cancer treatment firm, also experienced a 37% rise in its stock after raising US$139 million in its initial public offering.

NewsMiRXES Pte. Ltd. went public on May 15th '25.[WORLD] Singapore-based biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to fuel its next phase of growth.